This updated list will be a hands-on tool for governments to identify, procure, stockpile, and deliver effective treatments in a short time to those exposed.
WHO has updated its list of critical medicines that governments should be ready within the face of a radiological or a nuclear emergency.
It focuses on stockpiling pharmaceutical supplies that would be needed to treat radiation exposures. Iodide tablets, antiemetics, anti-diarrhoeal agents, incorporating agents, alkylating agents, and other medications have been included in the updated list.
It is the first time since 2007 that new medications have been added to the list. It is being speculated that the Russia-Ukraine war might have motivated WHO to update it. Having a ready supply of lifesaving medicines will reduce risks and treat injuries from radiation.
The revised report details the functions of the WHO and national health authorities in stockpile development. “As the leading international organization in public health with both the authority and responsibility to assist in health emergencies, WHO provides advice and guidance to countries on public health preparedness and response to radiation emergencies, including stockpile development,” the report says.
Additionally, the report cites the procedures followed by a few countries while creating and maintaining national stockpiles. These nations include Argentina, Brazil, France, Germany, the Republic of Korea, the Russian Federation, the United States, and France.
Nuclear power plant accidents and deliberate nuclear weapon detonations during armed warfare are potential causes of radiological disasters.
